Richard Klausner, Director at Lyell Immunopharma, Inc. (LYEL), sold 11,100 shares at $6.40 ($71K) on 2022-09-23, disclosed to the SEC on 2022-09-27.
Open-market sale of $71k LYEL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| JUNO | SELL | 2018-01-09 | $1.2M | — | Filing → |
| JUNO | SELL | 2017-12-22 | $3.2M | — | Filing → |
| JUNO | SELL | 2017-09-08 | $1.0M | — | Filing → |